Sabine Tischer-Zimmermann - JoVE Visualize

Showing results (1-10 of 24) with videos related to

Pageof 3

Sort By:

International Journal of Molecular Sciences|March 23, 2019

Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L MicrobeadsCaroline Mangare, Sabine Tischer-Zimmermann, Sebastian B Riese, et al.

Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|February 28, 2022

Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell TherapyCaroline Mangare, Sabine Tischer-Zimmermann, Agnes Bonifacius, et al.

Transplantation and Cellular Therapy|March 19, 2023

Adenoviral Penton and Hexon Proteins Are Equivalent Immunogenic Targets of Virus-Specific T Cells after Hematopoietic Stem Cell Transplantation in ChildrenAstrid Wintering, Sabine Tischer-Zimmermann, Rebecca Schultze-Florey, et al.

Frontiers in Medicine|January 11, 2020

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-LymphocytesThomas Mika, Katharina Strate, Swetlana Ladigan, et al.

International Journal of Molecular Sciences|January 26, 2019

Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer ImmunotherapyDamaris A Schillingmann, Sebastian B Riese, Vijith Vijayan, et al.

Frontiers in Immunology|April 10, 2023

Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximabSabine Tischer-Zimmermann, Agnes Bonifacius, Maria Michela Santamorena, et al.

Frontiers in Medicine|December 13, 2021

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?Daniel Gussarow, Agnes Bonifacius, Anne Cossmann, et al.

Journal of Translational Medicine|April 3, 2020

High-intensity interval training in allogeneic adoptive T-cell immunotherapy - a big HIT?Nele Carolin Heinemann, Sabine Tischer-Zimmermann, Torge Christian Wittke, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025

Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 InfectionAstrid Wintering, Agnes Bonifacius, Sabine Tischer-Zimmermann, et al.

Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 24, 2019

Transfer of Hexon- and Penton-selected adenovirus-specific T cells for refractory adenovirus infection after haploidentical stem cell transplantationRebecca E Schultze-Florey, Sabine Tischer-Zimmermann, Hans-Gert Heuft, et al.

Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:

Pageof 3

International Journal of Molecular Sciences|March 23, 2019

Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L MicrobeadsCaroline Mangare, Sabine Tischer-Zimmermann, Sebastian B Riese, et al.

Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|February 28, 2022

Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell TherapyCaroline Mangare, Sabine Tischer-Zimmermann, Agnes Bonifacius, et al.

Transplantation and Cellular Therapy|March 19, 2023

Adenoviral Penton and Hexon Proteins Are Equivalent Immunogenic Targets of Virus-Specific T Cells after Hematopoietic Stem Cell Transplantation in ChildrenAstrid Wintering, Sabine Tischer-Zimmermann, Rebecca Schultze-Florey, et al.

Frontiers in Medicine|January 11, 2020

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-LymphocytesThomas Mika, Katharina Strate, Swetlana Ladigan, et al.

International Journal of Molecular Sciences|January 26, 2019

Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer ImmunotherapyDamaris A Schillingmann, Sebastian B Riese, Vijith Vijayan, et al.

Frontiers in Immunology|April 10, 2023

Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximabSabine Tischer-Zimmermann, Agnes Bonifacius, Maria Michela Santamorena, et al.

Frontiers in Medicine|December 13, 2021

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?Daniel Gussarow, Agnes Bonifacius, Anne Cossmann, et al.

Journal of Translational Medicine|April 3, 2020

High-intensity interval training in allogeneic adoptive T-cell immunotherapy - a big HIT?Nele Carolin Heinemann, Sabine Tischer-Zimmermann, Torge Christian Wittke, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025

Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 InfectionAstrid Wintering, Agnes Bonifacius, Sabine Tischer-Zimmermann, et al.

Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 24, 2019

Transfer of Hexon- and Penton-selected adenovirus-specific T cells for refractory adenovirus infection after haploidentical stem cell transplantationRebecca E Schultze-Florey, Sabine Tischer-Zimmermann, Hans-Gert Heuft, et al.

Pageof 3